February 28, 2015 12:42 AM ET

Healthcare Equipment and Supplies

Company Overview of Tangent Medical Technologies, Inc.

Company Overview

Tangent Medical Technologies, Inc., a development stage medical device company, focuses on the development and commercialization of IV therapy products. It offers NovaCath, a peripheral intravenous catheter system that integrates catheter stabilization, tubing management, closed system blood control, and passive needle encapsulation on IV start. The company develops Integrated Safety IV Catheter System to improve clinical outcomes and minimize occupational exposure to blood and standardize clinical practice; Advanced Catheter Stabilization that allows preserving catheter integrity; Next Generation Tubing Management to improve patient comfort and reduce various IV complications, including dis...

8170 Jackson Road

Ann Arbor, MI 48103

United States

Founded in 2009





Key Executives for Tangent Medical Technologies, Inc.

Chairman of The Board and Chief Executive Officer
Age: 48
Co-Founder and Director of Product Development
Co-Founder and Director of Marketing
Co-Founder and Director of Research & Development
Chief Financial Officer
Compensation as of Fiscal Year 2014.

Tangent Medical Technologies, Inc. Key Developments

GE Capital, Healthcare Financial Services Provides Credit Facility to Tangent Medical, Inc

GE Capital, Healthcare Financial Services announced that it has provided a $5 million senior secured term loan credit facility to Tangent Medical, Inc. GE Capital, Healthcare Financial Services is acting as agent and sole lender for the credit facility. The financing will be used to support the company's commercialization and development efforts.

Tangent Medical Announces U.S. Launch of the NovaCat Integrated Iv Catheter System

Tangent Medical announced its commercial product launch and start to clinical evaluations in several healthcare facilities across the U.S. The commercialization of this product is the first significant advancement in the IV catheter market in more than a decade. NovaCath is the first safety IV catheter offering advanced catheter stabilization technology designed to exceed the high CDC, OSHA and INS standards for IV catheter stabilization. Its passive needle shielding technology and closed system design minimizes occupational exposure to blood to the lowest feasible extent. Several patented design features uniquely position NovaCath to offer healthcare facilities uncompromising safety and satisfaction – both to the clinician and the patient. NovaCath's ergonomic design and soft materials will improve patient comfort and minimize the risk of pressure ulcers that can result from use of traditional catheters. In addition, its 180-degree fluid-path turn eliminates the J-Loop, which can cause IV tubing snags and catheter dislodgement. NovaCath's pre-assembled, all-in-one system minimizes IV catheter set-up time and risk of touch-point contamination.

Similar Private Companies By Industry

Company Name Region
Zimmer New England, Inc. United States
Syntervention, Inc. United States
LENSAR, Inc. United States
Pearl Brite Concepts, Inc. United States
FB Optical Manufacturing, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tangent Medical Technologies, Inc., please visit www.tangentmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.